Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamil J Cygan

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Genome Medicine|September 10, 2021
Non-cancer-related pathogenic germline variants and expression consequences in ten-thousand cancer genomesZishan Wang, Xiao Fan, Yufeng Shen, et al.
Molecular Medicine (Cambridge, Mass.)|August 24, 2018
Changes in the process of alternative RNA splicing results in soluble B and T lymphocyte attenuator with biological and clinical implications in critical illnessSean F Monaghan, Debasree Banerjee, Chun-Shiang Chung, et al.
Journal for Immunotherapy of Cancer|March 22, 2024
Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphomaJurriaan Brouwer-Visser, Nathalie Fiaschi, Raquel P Deering, et al.
Nature Reviews. Cancer|March 25, 2016
The importance of p53 pathway genetics in inherited and somatic cancer genomesGiovanni Stracquadanio, Xuting Wang, Marsha D Wallace, et al.
Science Translational Medicine|March 26, 2025
CAR T cells based on fully human T cell receptor-mimetic antibodies exhibit potent antitumor activity in vivoRobert Salzler, David J DiLillo, Kei Saotome, et al.
Nature Medicine|June 15, 2023
Intratumoral dendritic cell-CD4<sup>+</sup> T helper cell niches enable CD8<sup>+</sup> T cell differentiation following PD-1 blockade in hepatocellular carcinomaAssaf Magen, Pauline Hamon, Nathalie Fiaschi, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Genome Medicine|September 10, 2021
Non-cancer-related pathogenic germline variants and expression consequences in ten-thousand cancer genomesZishan Wang, Xiao Fan, Yufeng Shen, et al.
Molecular Medicine (Cambridge, Mass.)|August 24, 2018
Changes in the process of alternative RNA splicing results in soluble B and T lymphocyte attenuator with biological and clinical implications in critical illnessSean F Monaghan, Debasree Banerjee, Chun-Shiang Chung, et al.
Journal for Immunotherapy of Cancer|March 22, 2024
Molecular assessment of intratumoral immune cell subsets and potential mechanisms of resistance to odronextamab, a CD20×CD3 bispecific antibody, in patients with relapsed/refractory B-cell non-Hodgkin lymphomaJurriaan Brouwer-Visser, Nathalie Fiaschi, Raquel P Deering, et al.
Nature Reviews. Cancer|March 25, 2016
The importance of p53 pathway genetics in inherited and somatic cancer genomesGiovanni Stracquadanio, Xuting Wang, Marsha D Wallace, et al.
Science Translational Medicine|March 26, 2025
CAR T cells based on fully human T cell receptor-mimetic antibodies exhibit potent antitumor activity in vivoRobert Salzler, David J DiLillo, Kei Saotome, et al.
Nature Medicine|June 15, 2023
Intratumoral dendritic cell-CD4<sup>+</sup> T helper cell niches enable CD8<sup>+</sup> T cell differentiation following PD-1 blockade in hepatocellular carcinomaAssaf Magen, Pauline Hamon, Nathalie Fiaschi, et al.
Pageof 2